Where does Insuline Medical Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Insuline Medical Ltd ranks #29,098 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Insuline Medical Ltd hold?

Insuline Medical Ltd holds 9 US utility patents granted between 2015 and 2023, spanning 9 technology areas.

What is Insuline Medical Ltd's Innovation Score?

Insuline Medical Ltd has an Innovation Score of 37.9 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Insuline Medical Ltd's patent grant rate increasing or decreasing?

Insuline Medical Ltd's recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Insuline Medical Ltd's patents?

Insuline Medical Ltd's patents average 21.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Insuline Medical Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Insuline Medical Ltd

Q: What technology areas does Insuline Medical Ltd focus on?

Insuline Medical Ltd's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 8 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Insuline ranks #29,098 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#29,098
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.9/100): 21.1
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29098 · Foreign Corporation #29,098 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,098/49,997
PHOTO-FINISH Institute of…
CPC-NARROW A61M · 9 areas
INNOV-THIN 37.9/100
CLAIMS-DENSE 21.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Insuline Medical · this assignee

38
3D Lighting… · lowest

7

What this shows Insuline's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Insuline's grants concentrate

Insuline Medical Ltd is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2020. By volume, Insuline sits between Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Intellishot Holdings Inc..

Insuline's three-year grant acceleration

Insuline Medical Ltd shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Institute of Medi…

9
Instituto Potosin…

9
Inston

9
Instytut Wysokich…

9
Integra Lifescien…

9
Integrated Sensin…

9
Integrated Soluti…

9
Intellishot Holdi…

9
Insuline Medical ◀

9

What this shows Insuline holds 9 patents at rank #29,102, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Insuline

By rank, the assignees closest to #29,102 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Insuline's primary technology class.

Insuline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Insuline Medical Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	33.3%
2016	2	22.2%
2017	2	22.2%
2020	1	11.1%
2023	1	11.1%

Which technologies does Insuline Medical Ltd patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

A61B - DIAGNOSIS; SURGERY; Identification 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 1

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#29,098

of 49,997 tracked assignees

Innovation Score

37.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Insuline Medical Ltd's patent record in context - here's where to go next.

Insuline Medical Ltd's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 88.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #29,098 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Insuline Medical Ltd against Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.